These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49 related articles for article (PubMed ID: 21569906)
1. Imaging surveillance of differentiated thyroid cancer. Johnson NA; LeBeau SO; Tublin ME Radiol Clin North Am; 2011 May; 49(3):473-87, vi. PubMed ID: 21569906 [TBL] [Abstract][Full Text] [Related]
2. Postoperative surveillance of differentiated thyroid carcinoma: rationale, techniques, and controversies. Johnson NA; Tublin ME Radiology; 2008 Nov; 249(2):429-44. PubMed ID: 18936309 [TBL] [Abstract][Full Text] [Related]
3. [Taking of position in relationship to the protocol of the current treatment of thyroid nodules and differentiated thyroid cancer]. Gómez Sáez JM Endocrinol Nutr; 2010 Oct; 57(8):370-5. PubMed ID: 20850397 [No Abstract] [Full Text] [Related]
4. Circulating thyroid cancer markers. Gupta M; Chia SY Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):383-8. PubMed ID: 17940468 [TBL] [Abstract][Full Text] [Related]
5. [Diagnosis, treatment and follow-up in the case of differentiated thyroid cancer]. Lind P; Igerc I; Kohlfürst S Wien Med Wochenschr; 2005 Oct; 155(19-20):429-35. PubMed ID: 16424998 [TBL] [Abstract][Full Text] [Related]
6. Diagnosis and treatment of differentiated thyroid carcinoma. Cox AE; LeBeau SO Radiol Clin North Am; 2011 May; 49(3):453-62, vi. PubMed ID: 21569904 [TBL] [Abstract][Full Text] [Related]
7. Thyroglobulin measurement vs iodine 131 total-body scan for follow-up of well-differentiated thyroid cancer. Aiello DP; Manni A Arch Intern Med; 1990 Feb; 150(2):437-9. PubMed ID: 2105703 [TBL] [Abstract][Full Text] [Related]
8. Follow-up of differentiated thyroid carcinoma. Pagano L; Klain M; Pulcrano M; Angellotti G; Pasano F; Salvatore M; Lombardi G; Biondi B Minerva Endocrinol; 2004 Dec; 29(4):161-74. PubMed ID: 15765026 [TBL] [Abstract][Full Text] [Related]
9. Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma. Frasoldati A; Pesenti M; Gallo M; Caroggio A; Salvo D; Valcavi R Cancer; 2003 Jan; 97(1):90-6. PubMed ID: 12491509 [TBL] [Abstract][Full Text] [Related]
10. Thyroglobulin: a specific serum marker for the management of thyroid carcinoma. Whitley RJ; Ain KB Clin Lab Med; 2004 Mar; 24(1):29-47. PubMed ID: 15157556 [TBL] [Abstract][Full Text] [Related]
11. Blood thyroglobulin and TSH receptor mRNA detection by RT-PCR in the follow-up of differentiated thyroid cancer patients. Torosian L; Manrique G; Alvarez B; Lago G; Roca R; Belzarena C Rev Esp Med Nucl; 2010; 29(3):109-13. PubMed ID: 20399540 [TBL] [Abstract][Full Text] [Related]
12. Recombinant human thyroid-stimulating hormone (Thyrogen) in thyroid cancer follow up: experience at a single institution. Wong R; Topliss DJ; Bach LA; Hamblin PS; Kalff V; Long F; Stockigt JR Intern Med J; 2009 Mar; 39(3):156-63. PubMed ID: 19383064 [TBL] [Abstract][Full Text] [Related]
13. Changing concepts in the management of differentiated thyroid cancer. Intenzo CM; Jabbour S; Dam HQ; Capuzzi DM Semin Nucl Med; 2005 Oct; 35(4):257-65. PubMed ID: 16150246 [TBL] [Abstract][Full Text] [Related]
14. Value of stimulated serum thyroglobulin levels for detecting persistent or recurrent differentiated thyroid cancer in high- and low-risk patients. Duren M; Siperstein AE; Shen W; Duh QY; Morita E; Clark OH Surgery; 1999 Jul; 126(1):13-9. PubMed ID: 10418587 [TBL] [Abstract][Full Text] [Related]